New combo therapy aims to shrink hard-to-treat sinus cancers before surgery
NCT ID NCT07281417
First seen Jan 07, 2026 · Last updated Jun 14, 2026 · Updated 31 times
Summary
This study is for people with a type of sinus cancer called sinonasal squamous cell carcinoma. It compares standard chemotherapy before surgery to chemotherapy plus an immunotherapy drug called cemiplimab. The goal is to see if adding immunotherapy helps shrink tumors more and improves how long patients stay cancer-free. About 108 adults with stage III or IV disease will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III SINONASAL CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University Comprehensive Cancer Center LAO
RECRUITINGColumbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UC Irvine Health/Chao Family Comprehensive Cancer Center
SUSPENDEDOrange, California, 92868, United States
-
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
SUSPENDEDIrvine, California, 92612, United States
-
University of Kentucky/Markey Cancer Center
SUSPENDEDLexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.